000 01132 a2200277 4500
005 20250512045128.0
264 0 _c19871209
008 198712s 0 0 eng d
022 _a0002-9149
024 7 _a10.1016/0002-9149(87)90589-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIllingworth, D R
245 0 0 _aHypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.
_h[electronic resource]
260 _bThe American journal of cardiology
_cOct 1987
300 _a33G-42G p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnticholesteremic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
650 0 4 _aHyperlipoproteinemia Type II
_xdrug therapy
650 0 4 _aLovastatin
_xanalogs & derivatives
650 0 4 _aSimvastatin
700 1 _aBacon, S
773 0 _tThe American journal of cardiology
_gvol. 60
_gno. 12
_gp. 33G-42G
856 4 0 _uhttps://doi.org/10.1016/0002-9149(87)90589-3
_zAvailable from publisher's website
999 _c3320203
_d3320203